IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-PASource pending

Mike Kelly disclosed SELL $BMY

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$15K – $50K
Filed
2026-06-12
Trade date
2026-05-07
Disclosure lag
36 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Source pending
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 36 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
43 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Mike Kelly, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 15 lobbying filings and 38 federal contract records.
MethodologyData sourcesReport a correction

Source

source pending
Source: indexed congressional disclosure; official source link pending · filed 2026-06-12 · disclosed 36d after transaction

Market context

Bristol-Myers Squibb Company

Sector: Healthcare

Post-trade move: 1.6%

Vs SPY: 0.2%

Factual flags

  • 15 lobbying filings linked to this ticker.
  • 38 federal contract records linked to this ticker.
  • 3 nearby same-ticker disclosures in the surrounding 30-day window.
  • Traded BMY 17d after lobbying filing by BRISTOL-MYERS SQUIBB COMPANY ($1,320,000)
  • Traded BMY 13d after federal contract with Department of Veterans Affairs ($364,139)

Member trail

Mike Kelly

U.S. House · PA-16

House Committee on Ways and Means

Ticker trail

$BMY

Bristol-Myers Squibb Company

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.